✦ LIBER ✦

Differential responses of serum and salivary interleukin-6 to acute strenuous exercise

✍ Scribed by M. Minetto; A. Rainoldi; M. Gazzoni; M. Terzolo; P. Borrione; A. Termine; L. Saba; A. Dovio; A. Angeli; P. Paccotti

Publisher: Springer
Year: 2004
Tongue: English
Weight: 338 KB
Volume: 93
Category: Article
ISSN: 1439-6319
DOI: 10.1007/s00421-004-1241-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-6 response to exercise durin

Interleukin-6 response to exercise during acute and chronic hypoxia

✍ Carsten Lundby; Adam Steensberg 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 259 KB

Changes in serum interleukin-6 and high-

Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin

✍ Yumei Luo; Deqian Jiang; Dan Wen; Jianxin Yang; Liying Li 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 231 KB

The serum angiotensin-converting enzyme

The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype

✍ David Woods; Julie Sanders; Alun Jones; Emma Hawe; Peter Gohlke; SteveE. Humphri 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 244 KB

Acute phase response to recombinant inte

Acute phase response to recombinant interleukin-6 and macrophage- and fibroblast-derived crude cytokine preparations in primary cultures of mouse hepatocytes

✍ H. Rokita; M. Mackiewicz; A. Koj 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

The response of T cells to interleukin-6

The response of T cells to interleukin-6 is differentially regulated by the microenvironment of the rheumatoid synovial fluid and tissue

✍ Ester Hidalgo; Sarah J. Essex; Lorraine Yeo; S. John Curnow; Andrew Filer; Mark 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 2 views

Thalidomide reduces serum C-reactive pro

Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy

✍ Igal Kedar; Wilmosh Mermershtain; Hefziba Ivgi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 341 KB

## Abstract Interleukin‐2 (IL‐2) has some antitumor activity in patients with renal cell carcinoma. It has been noted that response to IL‐2 and prognosis may be adversely affected by elevated serum levels of C‐reactive protein (CRP) or interleukin‐6 (IL‐6). We used thalidomide to treat patients wit